USTAR MultNAT MTB/RIF Assay officially approved by the China National Medical Products Administration (NMPA)!

A “Global Solution” for innovating the diagnosis of drug-resistant tuberculosis.

A “Global Solution” for innovating the diagnosis of drug-resistant tuberculosis.